fluorescein-5-isothiocyanate has been researched along with Thyroid Carcinoma, Anaplastic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, JC; Biswas, R; Chung, PS; Lee, SH; Moon, JH | 1 |
1 other study(ies) available for fluorescein-5-isothiocyanate and Thyroid Carcinoma, Anaplastic
Article | Year |
---|---|
Carboplatin synergistically triggers the efficacy of photodynamic therapy via caspase 3-, 8-, and 12-dependent pathways in human anaplastic thyroid cancer cells.
Topics: Annexin A5; Apoptosis; Blotting, Western; Carboplatin; Caspase 12; Caspase 3; Caspase 8; Caspases; Cell Cycle; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Cytochromes c; Endoplasmic Reticulum Stress; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; Membrane Potential, Mitochondrial; Mitochondrial Proteins; Photochemotherapy; Propidium; Reactive Oxygen Species; Signal Transduction; Thyroid Carcinoma, Anaplastic | 2014 |